High Dose Indomethacin for Patent Ductus Arteriosus Closure Increases Neonatal Morbidity.
Sign Up to like & getrecommendations! Published in 2019 at "American journal of perinatology"
DOI: 10.1055/s-0039-3400996
Abstract: OBJECTIVE  Symptomatic patent ductus arteriosus (sPDA) is the most common heart abnormality in preterm infants. Optimal duration and dose of medical treatment is still unclear. We assessed undesired effects and closure rate of high-dose indomethacin… read more here.
Keywords: patent ductus; closure; hdi; dose indomethacin ... See more keywords